Thursday, February 02, 2023 4:46:45 PM
There appears to be an estimated Phase 1 DMT completion date (this PY) of May 2023 and study data in June 2023 now. Not EOY as stated earlier in videos. Maybe I misunderstood the earlier comments, but,,,
Seems things are moving right along at CHDR in the Netherlands. Recruiting.
So, Ifenprodil CC trials start this summer along with DMT Phase 2a.?..?.
63% AlgernonNeuro (DMT) and 100% Algernon Ifenprodil-CC plus CKD eventually is what we own.?....Sounds great... That's a Buy @ these lows, IMO. .. I've been waiting but I'll start to move some money tomorrow and do that asap ...
You're buddy,,,
...GLTA...
https://www.clinicaltrials.gov/ct2/show/NCT05559931?term=DMT&cntry=NL&draw=2&rank=1
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM